TRANSPOSON THERAPEUTICS
Transposon Therapeutics operates as a pharmaceutical company based in Westport, Connecticut. It specializes in developing therapeutics for debilitating and life-threatening diseases
TRANSPOSON THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2019-01-01
Address:
Westport, Connecticut, United States
Country:
United States
Website Url:
http://www.transposonrx.com
Total Employee:
11+
Status:
Active
Technology used in webpage:
U.S. Server Location
Similar Organizations
![]()
Imagen Biotech
Imagen Biotech is focused on identifying and developing therapeutics for blinding diseases.
![]()
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Modis Therapeutics
Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.
Oralome
Oralome uses cutting edge technologies and therapeutics to enable precision health.
Revivo Therapeutics
Revivo Therapeutics is specializing in treating brain diseases.
![]()
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
StoreMyTumor
StoreMyTumor specializes in tumor preservation, advanced testing, and immune-therapy.
Strykagen
Strykagen manufactures transforming diagnostics and therapeutics for life-threatening rare muscle diseases.
TNeuroPharma
TNeuroPharma develops a therapeutic-based technology focusing on the T-cell contribution in tracking and treating neurodegenerative disease.
Current Advisors List
Current Employees Featured
![]()
Founder
![]()
Investors List
![]()
SV Health Investors
SV Health Investors investment in Seed Round - Transposon Therapeutics
Official Site Inspections
http://www.transposonrx.com Semrush global rank: 2.99 M Semrush visits lastest month: 5.25 K
- Host name: 253.24.180.107.host.secureserver.net
- IP address: 107.180.24.253
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260

More informations about "Transposon Therapeutics"
Transposon Therapeutics - Crunchbase Company Profile & Funding
Transposon Therapeutics operates as a pharmaceutical company based in Westport, Connecticut. It specializes in developing therapeutics for debilitating and life-threatening diseasesSee details»
Transposon Therapeutics, Inc.
Today, the only retrotransposons in our genome that are capable of becoming active are human-specific LINE-1 elements.Abnormal proteins that lead to neurodegenerative diseases, such as …See details»
Transposon 2025 Company Profile: Valuation, Funding …
Www.transposonrx.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 4660 La Jolla Village Drive; Suites 100 and 200; San Diego, CA 92122; United States +1 (858) Primary …See details»
Transposon Therapeutics - 2025 Company Profile - Tracxn
Developer of therapeutics for the treatment of neurodegenerative diseases. The company is developing TPN-101 (also known as Censavudine) and other LINE-1 reverse transcriptase …See details»
Transposon Therapeutics, Inc. | LinkedIn
Transposon Therapeutics, Inc. | 48 followers on LinkedIn. Transformational therapies for neurodegenerative and aging-related diseasesSee details»
Transposon Therapeutics, Inc. - Drug pipelines, Patents, Clinical ...
Www.transposonrx.com. Startups | Holding Company | 2019 | Connecticut, United States | 10-50 | www.transposonrx.com. Last update 23 Jan 2025. Overview. Pipeline. Deal. Translational …See details»
Transposon Therapeutics, Inc. - VentureRadar
Website: https://www.transposonrx.com/ Develops innovative treatments for neurodegenerative diseases like ALS and FTD, focusing on TPN-101 to combat neurotoxic ...See details»
Transposon Therapeutics - VentureRadar
Censavudine is an orally available small molecule thymidine analogue being developed by Transposon Therapeutics under a license from Oncolys. Transposon Therapeutics was …See details»
Transposon Therapeutics | F6S
Similar companies Tune Therapeutics Sonoma Biotherapeutics PharmatrophiX, Inc Biotech company focused on developing therapeutic drugs TScan Therapeutics Retex …See details»
Transposon Therapeutics, Inc.
Our lead reverse transcriptase inhibitor, TPN-101, is the most potent known inhibitor of LINE-1 reverse transcriptase and has excellent systemic and brain bioavailability with once daily oral …See details»
Transposon Therapeutics - Canaan
Transposon Therapeutics, Inc. is developing TPN-101 (also known as Censavudine) and other LINE-1 reverse transcriptase inhibitors for the treatment of rare neurodegenerative diseases …See details»
Team - Transposon Therapeutics, Inc.
With > 30 years of experience across multiple therapeutic areas, Michael has held R&D positions at Merck and BMS prior to joining BI as Preclinical TA Head Virology and Infectious Disease …See details»
Transposon Therapeutics - Contacts, Employees, Board Members, …
Organization. Transposon Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Number of …See details»
Transposon Therapeutics - Products, Competitors, Financials, …
Headquarters Location. 4660 La Jolla Village Drive Suites 100 and 200. San Diego, California, 92122, United States. 858-535-4821See details»
Transposon Inc.
Contact Info 30 Kern Road Toronto, Ontario M3B 1T1, Canada Tel: 416.391.4400 Fax: 416.447.6500 [email protected]: Our vision is to enable the successful growth of …See details»
Transposon Receives US FDA Fast Track Designation for TPN-101 …
May 21, 2024 The designation of TPN-101 as a Fast Track product for PSP is supported by data from a Phase 2, randomized, double-blind, placebo-controlled study of TPN-101 in patients …See details»
Transposon to Present Results from Phase 2 Study of TPN-101 for …
Oct 15, 2024 Transposon Therapeutics, a biotechnology company developing a platform of novel, orally administered therapies for the treatment of neurodegenerative and aging-related …See details»
Transposon Therapeutics-Transposon Therapeutics, Inc.-企业详情 …
查看医药魔方InvestGO®数据库Transposon Therapeutics的公司信息。Transposon Therapeutics(Transposon Therapeutics, Inc.),公司简介:Transposon is a new …See details»
Science - Transposon Therapeutics, Inc.
Today, the only retrotransposons in our genome that are capable of becoming active are human-specific LINE-1 elements.Abnormal proteins that lead to neurodegenerative diseases, such as …See details»